Resources

Type of publications
Regions
Diseases

5255 results found

2021 ∙ Kaur, R. J. Dutta, S. Bhardwaj, P. Charan, J. Dhingra, S. Mitra, P. Singh, K. Yadav, D. Sharma, P. Misra, S.

Adverse Events Reported From  COVID-19 Vaccine Trials: A Systematic Review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Alhumaid, S. Al Mutair, A. Al Alawi, Z. Rabaan, A. A. Tirupathi, R. Alomari, M. A. Alshakhes, A. S. Alshawi, A. M. Ahmed, G. Y. Almusabeh, H. M. Alghareeb, T. T. Alghuwainem, A. A. Alsulaiman, Z. A. Alabdulmuhsin, M. A. AlBuwaidi, E. A. Dukhi, A. K. B. Mufti, H. N. Al-Qahtani, M. Dhama, K. Al-Tawfiq, J. A. Al-Omari, A.

Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Gagelmann, N. Passamonti, F. Wolschke, C. Massoud, R. Niederwieser, C. Adjallé, R. Mora, B. Ayuk, F. Kröger, N.

Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2021 ∙ Wall, D. J. Patel, M. M. Chung, J. R. Lee, B. Dawood, F. S.

Antibody Response and Protection After Receipt of Inactivated Influenza Vaccine: A Systematic Review

  • Children
  • Newborn
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Guven, D. C. Sahin, T. K. Kilickap, S. Uckun, F. M.

Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ You, Z. Zhou, W. Weng, J. Feng, H. Liang, P. Li, Y. Shi, F.

Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-analysis

  • All age groups
  • Efficacy/effectiveness
  • Administration
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Nasser, R. Rakedzon, S. Dickstein, Y. Mousa, A. Solt, I. Peterisel, N. Feldman, T. Neuberger, A.

Are all vaccines safe for the pregnant traveller? A systematic review and meta-analysis

  • Pregnant women
  • Travellers
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Do, E. K. Rossi, B. Miller, C. A. Ksinan, A. J. Wheeler, D. C. Chukmaitov, A. Cyrus, J. W. Fuemmeler, B. F.

Area-Level Variation and Human Papillomavirus Vaccination among Adolescents and Young Adults in the United States: A Systematic Review

  • Americas
  • United States of America
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Coverage
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Vassallo, A. Dunbar, K. Ajuwon, B. Lowbridge, C. Kirk, M. King, C. Sheel, M.

Assessing the impact of polio supplementary immunisation activities on routine immunisation and health systems: a systematic review

  • Children
  • Newborn
  • Poliomyelitis
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Sanftenberg, L. Kuehne, F. Anraad, C. Jung-Sievers, C. Dreischulte, T. Gensichen, J.

Assessing the impact of shared decision making processes on influenza vaccination rates in adult patients in outpatient care: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...